The functional brain imaging system market has seen considerable growth due to a variety of factors.
• The market size of the functional brain imaging system has significantly expanded in the recent past. Anticipated growth from $4.72 billion in 2024 to $5.08 billion in 2025 at a CAGR of 7.6% is forecasted.
The previous growth can be credited to factors such as a rise in severe health ailments, growth in neurological disorder cases, an uptick in traumatic brain injuries, an escalation in brain cancer occurrences, and an increased preference for non-invasive and minimally invasive devices.
The functional brain imaging system market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipating robust expansion in the coming years, the market size for the functional brain imaging system is projected to reach $6.71 billion in 2029 with a compound annual growth rate (CAGR) of 7.2%.
Factors influencing the growth during the forecast period include a higher frequency of road accidents, the growing significance of brain imaging, a surge in dementia cases, enhanced awareness about neurodegenerative afflictions, an increasing aging populace, and escalated investment in healthcare. Key trends expected during the forecast period encompass integration of multi-modal imaging, advancement in portable electroencephalogram (EEG) devices, modernized electrode designs, transcranial electrical stimulation (TES), and incorporation of artificial intelligence (AI).
The escalating occurrence of brain cancer is anticipated to stimulate the expansion of the functional brain imaging system market in the future. Brain cancer represents a condition where abnormal cells proliferate uncontrollably in the brain, producing a tumor that can disrupt brain functions. Factors such as an aging populace, superior detection techniques, environmental hazards, and enhanced reporting contribute to the prevalence of brain cancer. Functional brain imaging systems improve the precision of the diagnosis, recommend safer and more efficient treatment protocols, and offer ongoing surveillance to enhance the prognosis for patients with brain cancer. For instance, Cancer Australia, a governmental agency for cancer control in Australia, stated in January 2024 that in 2021 there were 1,552 deaths from brain cancer in Australia (945 males and 607 females). This figure is projected to increase to 1,579 deaths in 2023 (969 males and 610 females). Therefore, the escalating occurrence of brain cancer fuels the expansion of the functional brain imaging system market.
The functional brain imaging system market covered in this report is segmented –
1) By Type: Functional Magnetic Resonance Imaging (fMRI) Systems, Functional Near Infrared Spectroscopy (fNIRS) Systems, Positron Emission Tomography (PET) System, Others Types
2) By Application: Hospital, Diagnostic imaging center, Other Applications
3) By End-User: Neurology, Psychiatry, Oncology, Cognitive Science
Subsegments:
1) By Functional Magnetic Resonance Imaging (fMRI) Systems: Research-Grade fMRI Systems, Clinical fMRI Systems, High-Field fMRI Systems, Resting-State fMRI Systems
2) By Functional Near Infrared Spectroscopy (fNIRS) Systems: Portable fNIRS Systems, Multi-Channel fNIRS Systems, Wearable fNIRS Devices, Clinical fNIRS Systems
3) By Positron Emission Tomography (PET) Systems: Whole-Body PET Systems, Dedicated Brain PET Systems, PET/CT Hybrid Systems, PET/MRI Hybrid Systems
4) By Other Types: Electroencephalography (EEG) Systems, Magnetoencephalography (MEG) Systems, Diffusion Tensor Imaging (DTI) Systems, Transcranial Magnetic Stimulation (TMS) Systems
Leading firms in the functional brain imaging system market are focused on creating novel solutions such as pulse sequence technology, aiming to augment image resolution, raise diagnostic precision, and cut down scan times, resulting in more potent and speedy brain imaging methods. This technology in functional brain imaging systems involves a sequence of synchronized radiofrequency (RF) pulses and magnetic field inclines used during an MRI scan to manipulate image generation by the MRI system. For instance, in July 2024, Fujifilm Holdings Corporation, a photography film manufacturing company from Japan, unveiled Aperto Lucent, an open 0.4-tesla MRI system. This system integrates RADAR motion compensating pulse sequence technology that decreases the necessity for repeat scans and controls motion distortions commonly encountered in MRI exams. The Aperto Lucent leverages Fujifilm's acclaimed permanent magnet technology, which eases installation and lowers operational expenses by reducing the requirement for extra equipment to uphold the magnetic field.
Major companies operating in the functional brain imaging system market are:
• Siemens Healthineers AG
• General Electric HealthCare Technologies Inc.
• NordicNeuroLab AS
• Koninklijke Philips N.V.
• Shimadzu Corporation
• Toshiba International Corporation
• Elekta AB
• Canon Medical Systems Corporation
• Cortech Solutions Inc.
• Compumedics Ltd.
• Brain Products GmbH
• Aspect Imaging Ltd.
• ANT Neuro GmbH
• BIOPAC Systems Inc.
• Neuroelectrics Corporation
• Twente Medical Systems International(TMSI) B.V.
• Advanced Brain Monitoring Inc.
• Gowerlabs Ltd.
• Artinis Medical Systems B.V.
• NIRx Medical Technologies LLC
North America was the largest region in the functional brain imaging system market in 2024. The regions covered in the functional brain imaging system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.